9.02 USD
+0.08 (+0.89%)
9.02 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to CCRN. CCRN was compared to 103 industry peers in the Health Care Providers & Services industry. While CCRN has a great health rating, its profitability is only average at the moment. CCRN does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- CCRN had positive earnings in the past year.
- In the past year CCRN had a positive cash flow from operations.
- In multiple years CCRN reported negative net income over the last 5 years.
- CCRN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- CCRN has a Return On Assets of -2.91%. This is in the lower half of the industry: CCRN underperforms 60.19% of its industry peers.
- With a Return On Equity value of -3.84%, CCRN perfoms like the industry average, outperforming 48.54% of the companies in the same industry.
- CCRN's Return On Invested Capital of 0.98% is in line compared to the rest of the industry. CCRN outperforms 42.72% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for CCRN is significantly above the industry average of 9.21%.
- The 3 year average ROIC (15.05%) for CCRN is well above the current ROIC(0.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.91% | ||
| ROE | -3.84% | ||
| ROIC | 0.98% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
1.3 Margins
- CCRN has a Operating Margin (0.56%) which is in line with its industry peers.
- In the last couple of years the Operating Margin of CCRN has declined.
- CCRN has a Gross Margin (20.19%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of CCRN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.56% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% |
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCRN is still creating some value.
- The number of shares outstanding for CCRN has been reduced compared to 1 year ago.
- Compared to 5 years ago, CCRN has less shares outstanding
- There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- CCRN has an Altman-Z score of 4.50. This indicates that CCRN is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of CCRN (4.50) is better than 78.64% of its industry peers.
- CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.5 |
ROIC/WACC0.11
WACC8.9%
2.3 Liquidity
- CCRN has a Current Ratio of 3.45. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
- CCRN has a better Current ratio (3.45) than 85.44% of its industry peers.
- A Quick Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
- CCRN's Quick ratio of 3.45 is amongst the best of the industry. CCRN outperforms 87.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.45 |
3. Growth
3.1 Past
- The earnings per share for CCRN have decreased strongly by -82.86% in the last year.
- Measured over the past years, CCRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.57% on average per year.
- Looking at the last year, CCRN shows a very negative growth in Revenue. The Revenue has decreased by -22.14% in the last year.
- CCRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.33% yearly.
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
3.2 Future
- Based on estimates for the next years, CCRN will show a very negative growth in Earnings Per Share. The EPS will decrease by -33.46% on average per year.
- CCRN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.58% yearly.
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 75.17, CCRN can be considered very expensive at the moment.
- The rest of the industry has a similar Price/Earnings ratio as CCRN.
- CCRN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.21.
- A Price/Forward Earnings ratio of 74.73 indicates a quite expensive valuation of CCRN.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of CCRN is on the same level as its industry peers.
- CCRN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.98.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75.17 | ||
| Fwd PE | 74.73 |
4.2 Price Multiples
- 79.61% of the companies in the same industry are more expensive than CCRN, based on the Enterprise Value to EBITDA ratio.
- 91.26% of the companies in the same industry are more expensive than CCRN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.47 | ||
| EV/EBITDA | 8.32 |
4.3 Compensation for Growth
- A cheap valuation may be justified as CCRN's earnings are expected to decrease with -33.46% in the coming years.
PEG (NY)N/A
PEG (5Y)3.06
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
5. Dividend
5.1 Amount
- No dividends for CCRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CROSS COUNTRY HEALTHCARE INC / CCRN FAQ
What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCRN.
What is the valuation status for CCRN stock?
ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.
Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?
CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for CCRN stock?
The Earnings per Share (EPS) of CROSS COUNTRY HEALTHCARE INC (CCRN) is expected to decline by -76.58% in the next year.